Literature DB >> 18940744

Options for radiotherapy in the treatment of liver metastases.

Joan Manel Gasent Blesa1, Laura A Dawson.   

Abstract

Technologic advances have provided the means to deliver tumoricidal doses of radiation therapy (RT) to patients with unresectable colorectal liver metastases, while avoiding critical normal tissues, providing the opportunity to use RT for curative intent treatment of metastatic disease. For the current report, the expanded role of RT, with its different techniques in the setting of metastatic colorectal cancer, from palliation to cure was reviewed.

Entities:  

Mesh:

Year:  2008        PMID: 18940744     DOI: 10.1007/s12094-008-0264-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  54 in total

1.  Brachytherapy in the treatment of solitary colorectal metastases to the liver.

Authors:  D Donath; D Nori; A Turnbull; N Kaufman; J G Fortner
Journal:  J Surg Oncol       Date:  1990-05       Impact factor: 3.454

2.  Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies.

Authors:  L A Dawson; C J McGinn; D Normolle; R K Ten Haken; S Walker; W Ensminger; T S Lawrence
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

3.  Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases.

Authors:  Alan W Katz; Madeleine Carey-Sampson; Ann G Muhs; Michael T Milano; Michael C Schell; Paul Okunieff
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-29       Impact factor: 7.038

4.  Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases.

Authors:  R S Stubbs; R J Cannan; A W Mitchell
Journal:  Hepatogastroenterology       Date:  2001 Mar-Apr

5.  Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.

Authors:  R S Witte; A Cnaan; E G Mansour; E Barylak; J E Harris; A J Schutt
Journal:  Cancer       Date:  2001-03-01       Impact factor: 6.860

6.  Overview of clinical experiences on carbon ion radiotherapy at NIRS.

Authors:  Hirohiko Tsujii; Jun-Etsu Mizoe; Tadashi Kamada; Masayuki Baba; Shingo Kato; Hirotoshi Kato; Hiroshi Tsuji; Shigeru Yamada; Shigeo Yasuda; Tatsuya Ohno; Takeshi Yanagi; Azusa Hasegawa; Toshiyuki Sugawara; Hidefumi Ezawa; Susumu Kandatsu; Kyosan Yoshikawa; Riwa Kishimoto; Tadaaki Miyamoto
Journal:  Radiother Oncol       Date:  2004-12       Impact factor: 6.280

7.  Respiratory gated irradiation system for heavy-ion radiotherapy.

Authors:  S Minohara; T Kanai; M Endo; K Noda; M Kanazawa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-07-01       Impact factor: 7.038

8.  Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells.

Authors:  Chia Hung Chou; Pei-Jer Chen; Po-Huang Lee; Ann-Lii Cheng; Hui-Chen Hsu; Jason Chia-Hsien Cheng
Journal:  Clin Cancer Res       Date:  2007-02-01       Impact factor: 12.531

9.  Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients.

Authors:  H Blomgren; I Lax; I Näslund; R Svanström
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

10.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Regina V Tse; Maria Hawkins; Gina Lockwood; John J Kim; Bernard Cummings; Jennifer Knox; Morris Sherman; Laura A Dawson
Journal:  J Clin Oncol       Date:  2008-01-02       Impact factor: 44.544

View more
  1 in total

1.  Patterns of prescribing radiotherapy and bevacizumab in nationwide practice - analysis of 101 designated cancer care hospitals in Japan.

Authors:  Yoichiro Tsukada; Fumiaki Nakamura; Momoko Iwamoto; Atsuro Terahara; Takahiro Higashi
Journal:  J Radiat Res       Date:  2015-12-09       Impact factor: 2.724

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.